IL-28A/B (IFN-lambda 2/3) ELISA DY1789B-05 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemIL-28A/B (IFN-lambda 2/3) ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $450.00Supplier Page View Company Product Page
Catalog NumberDY1789B-05
NCBI Full Gene Nameinterferon lambda 2
NCBI Gene AliasesIFNL2a, IFNL3a, IL-28A, IL28A
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
Detection TargetIL-28A/B (IFN-lambda 2/3)
ReactivityMouse
Detection Range31.20 - 2000 pg/mL
ApplicationsELISA
Quantity1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Toll-like receptor 7 (TLR7)-mediated antiviral response protects mice from lethal SARS-CoV-2 infectionJournal of VirologyMay 20, 2025Roshan Ghimire, Rakshya Shrestha, Radhika Amaradhi, Lin Liu, Sunil More, Thota Ganesh, Alexandra K. Ford, Rudragouda Channappanavarwere assayed using commercially available ELISA kits (IFNβ, R&D Systems #DY8234-05; IFNλ, R&D Systems #DY1789B-05; TNF, BD Biosciences #558534; IL1β, R&D Systems #DY401; MCP-1, BD Biosciences #555260) according to

(2) Therapeutic JAK inhibition does not impact lung injury during viral or bacterial pneumonia in male micePhysiological reportsFebruary 1, 2025Sharma L, Singh RB, Ngeow C, van der Geest R, Duray AM, Tolman NJ, McVerry BJ, Dela Cruz CS, Alcorn JF, Bain W, et al.

(3) 7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectivelyEMBO molecular medicineOctober 1, 2024Gaur KK, Asuru TR, Srivastava M, Singh N, Purushotham N, Poojary B, Das B, Bhattacharyya S, Asthana S, Guchhait P.

(4) Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based VaccineVaccines (Basel)July 12, 2024Sebenzile K. Myeni, Anouk A. Leijs, Peter J. Bredenbeek, Shessy Torres Morales, Marissa E. Linger, Cyrielle Fougeroux, Sophie van Zanen-Gerhardt, Serge A. L. Zander, Adam F. Sander, Marjolein Kikkert(DY406-05, R&D Systems, Minneapolis, MN, USA), IFN-λ (D485-05, R&D Systems, Minneapolis, MN, USA), IFN-Υ (DY1789B-05, R&D Systems, Minneapolis, USA), and IL-1β (D401-05, R&D Systems, Minneapolis, USA) were used following

(5) IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humansInfection and immunityFebruary 13, 2024De M, Sukla S, Bharatiya S, Keshri S, Roy DG, Roy S, Dutta D, Saha S, Ejazi SA, Ravichandiran V, et al.

(6) Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2Nature communicationsDecember 12, 2023Hilligan KL, Namasivayam S, Clancy CS, Baker PJ, Old SI, Peluf V, Amaral EP, Oland SD, O'Mard D, Laux J, et al.

(7) Nei-like DNA glycosylase 2 selectively antagonizes interferon-β expression upon respiratory syncytial virus infectionThe Journal of biological chemistryAugust 1, 2023Pan L, Xue Y, Wang K, Zheng X, Islam A, Tapryal N, Chakraborty A, Bacsi A, Ba X, Hazra TK, et al.

(8) Reducing off-target drug accumulation by exploiting a type-III interferon responseJournal of Controlled ReleaseJune 1, 2023Scott G. Tilden, Madison H. Ricco, Emily A. Hemann, Thomas J. Anchordoquyusing the manufacturer’s recommendations and protocols. Mouse IL-28A/B (IFN-lambda 2/3) DuoSet® ELISA (DY1789B-05) was purchased from R&D Systems® (Minneapolis, MN). Quantification of Doxorubicin Fluorescence and

(9) Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinaseNature CommunicationsFebruary 28, 2023Sebenzile K. Myeni, Peter J. Bredenbeek, Robert C. M. Knaap, Tim J. Dalebout, Shessy Torres Morales, Igor A. Sidorov, Marissa E. Linger, Nadia Oreshkova, Sophie van Zanen-Gerhardt, Serge A. L. Zander, et al.R&D Systems), TNF-α (DY410-05, R&D Systems), IL-6 (DY406-05, R&D Systems), IFN-λ(D485-05, R&D Systems), IFN-Υ (DY1789B-05, R&D Systems), and IL-1β (D401-05, R&D Systems) were used according to the manufacturer’s instructions. Passive

(10) Intestinal antiviral signaling is controlled by autophagy gene Epg5 independent of the microbiotaAutophagyMay 1, 2022Lee S, Kalugotla G, Ingle H, Rodgers R, Wu C, Wang Y, Li Y, Yang X, Zhang J, Borella NR, et al.were collected and IFNL2 and IFNL3 levels were analyzed by ELISA as described previously (R&D Systems, DY1789B05) [50]. RNA extraction and quantitative reverse transcription-PCR As previously described [30], RNA

(11) A genetic screen identifies a protective type III interferon response to Cryptosporidium that requires TLR3 dependent recognitionPLoS pathogensMay 1, 2022Gibson AR, Sateriale A, Dumaine JE, Engiles JB, Pardy RD, Gullicksrud JA, O'Dea KM, Doench JG, Beiting DP, Hunter CA, et al.

(12) IL-20 Cytokines Are Involved in Epithelial Lesions Associated with Virus-Induced COPD Exacerbation in MiceBiomedicinesDecember 5, 2021Le Roux M, Ollivier A, Kervoaze G, Beke T, Gillet L, Pichavant M, Gosset P.

(13) A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cellsPLoS pathogensAugust 1, 2021Ko YA, Yu YH, Wu YF, Tseng YC, Chen CL, Goh KS, Liao HY, Chen TH, Cheng TR, Yang AS, et al.

(14) DHX15 is required to control RNA virus-induced intestinal inflammationCell reportsJune 22, 2021Xing J, Zhou X, Fang M, Zhang E, Minze LJ, Zhang Z.

(15) Murine astrovirus tropism for goblet cells and enterocytes facilitates an IFN-λ response in vivo and in enteroid culturesMucosal immunologyMay 1, 2021Ingle H, Hassan E, Gawron J, Mihi B, Li Y, Kennedy EA, Kalugotla G, Makimaa H, Lee S, Desai P, et al.

(16) Murine Type III interferons are functionally redundant and correlate with bacterial burden during influenza/bacterial super-infectionPloS oneJanuary 1, 2021Rich HE, Antos D, McCourt CC, Zheng WQ, Devito LJ, McHugh KJ, Gopal R, Wang J, Alcorn JF.

(17) Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupusProceedings of the National Academy of Sciences of the United States of AmericaMarch 10, 2020Goel RR, Wang X, O'Neil LJ, Nakabo S, Hasneen K, Gupta S, Wigerblad G, Blanco LP, Kopp JB, Morasso MI, et al.

(18) Distinct roles for MDA5 and TLR3 in the acute response to inhaled double-stranded RNAPloS oneJanuary 1, 2019Veazey JM, Chapman TJ, Smyth TR, Hillman SE, Eliseeva SI, Georas SN.

(19) Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbationsNature communicationsJune 8, 2018Singanayagam A, Glanville N, Girkin JL, Ching YM, Marcellini A, Porter JD, Toussaint M, Walton RP, Finney LJ, Aniscenko J, et al.

(20) Initial Influenza Virus Replication Can Be Limited in Allergic Asthma Through Rapid Induction of Type III Interferons in Respiratory EpitheliumFrontiers in immunologyJanuary 1, 2018An S, Jeon YJ, Jo A, Lim HJ, Han YE, Cho SW, Kim HY, Kim HJ.

Be the First to Write a Review!

IL-28A/B (IFN-lambda 2/3) ELISA

IL-28A/B (IFN-lambda 2/3) ELISA

IL-28A/B (IFN-lambda 2/3) ELISA from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (28)

Reviews

IL-28A/B (IFN-lambda 2/3) ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map